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ABSTRACT
Alradi, Fahad Mohammed. M.S. Department of Microbiology and Immunology, Wright
State University, 2018. The Response of Unpolarized Macrophage (RAW
264.7)/Keratinocytes (PAM-212) Monolayer and Co-Culture System to Herpes Simplex
Virus Type 1 (HSV-1) Replication during the Infection.

Keratinocytes and neurons cells are the main target for Herpes Simplex Virus Type 1
(HSV-1) invasion. Moreover, keratinocytes are the most abundant cell types in the
epidermis layer in the skin. Therefore, they are the first cells to encounter HSV-1 in the
primary infection. Next, the virus reaches the nerve endings and is transferred to neuronal
cells as a result from the primary infection. In between these two events, innate immune
cells including monocytes and macrophages response is activated and recruited to the
infection site. In this study, keratinocytes (PAM-212) and murine macrophage (RAW
264.7) cell lines were utilized to investigate the response of macrophages (RAW 264.7 )
and keratinocytes (PAM-212) to HSV-1 infection and propagation in vitro. In this study,
initially keratinocytes (PAM-212) and macrophages (RAW 264.7) and were studied
either infected or uninfected with HSV-1 at MOI 0.1 in a monolayer model. Cell lines
were co-cultured at ratio 1:5 (macrophages : keratinocytes) respectively in the co-culture
model 1. The results showed some differences and similarities in cell viabilities, and viral
replication between keratinocytes (PAM-212) and macrophages (RAW 264.7) at 24, 48,
and 72 hours. In both the monolayer and the co-culture model, cells were exhibited
morphological changes including irregularly shaped or rounded cells, enlargement of cell
size, and cells appeared in different density compared to neighboring cells especially in
the earlier phase of infection at 24 and 48 hours.
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In contrast, at 72 hours cells were degraded, detached, and more debris was
observed in the medium. In like manner, our results of cell viability showed some
variations after 24, 48, and 72 hours which confirms the HSV-1 infection.
Furthermore, plaque assay showed a significant decrease in HSV-1 titers at 24 hours
in the co-culture model compared to keratinocytes and macrophages monolayers.
However, the keratinocyte monolayer appeared to tolerate HSV-1 replication and
virus titers kept increasing in all time-points.
On the other hand, the macrophage monolayer exhibited a noticeable decrease in
the virus concentration at 48 hours, indicating the role of macrophages restricting
viral replication. The effect of macrophages was diminished as time increased, but
still exhibited a reduction in the virus titers compared to the keratinocytes and coculture at 72 hours. That suggests a pivotal role of macrophages to induce immune
response that limits viral replication as we proposed in our hypothesis. We still
believe in the role of the cytokines produced by macrophages such as interferons
IFN-α/β and interleukin IL-1α/β as antiviral therapy.
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HYPOTHESIS
The hypothesis of this study is that mimicking an in-vivo immune response can be
induced in a co-culture model as macrophages (RAW 264.7) exposed to keratinocytes
infected with HSV-1. Macrophages (RAW 264.7) would restrict HSV-1 replication
within keratinocytes and clear the infection.
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INTRODUCTION
Herpes Simplex Virus type 1(HSV-1), is one of the most prevalent human pathogens
among Herpesviridae family and causes oral and genital herpes infection, ocular
infection, and encephalitis 2. It infects numerous types of cells, including keratinocytes
and neurons, which are the main target for a HSV infection. However, the HSV-1
infection may turn systemic and fatal in young children and immunocompromised people
3

. Moreover, HSV-1 is contributed to 60 – 80% of herpesvirus infections in human

worldwide and persists for life-long in people who are exposed to the infection 4. The
HSV-1infection may also induce some symptoms represented in fever, painful vesicles,
tingling, abnormal sensation, itching, and burning in the lesions occurring in mouth and
face 5. HSV-1 consists of a linear genome, double-stranded DNA, and envelope that
carries approximately 13 glycoproteins on the lipid envelope involving in various
functions leading to integration into the host cell 6 (Figure: 1).

Figure 1: The Structure of Herpes Simplex Virus Type 1 (HSV-1).
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Keratinocytes and HSV-1 Entry:
Skin is a very important natural defense barrier to protect the body from external
environments 7. It is composed of two main layers: dermis and epidermis. The dermis
layer is rich in nerves and blood vessels while the epidermis layer consists of different
cell types including melanocytes, Langerhans cells, and Merkel cells, but keratinocytes
are the major resident in the epidermis in the skin 8. Oral mucosa has a similar structure
to the skin and rich in keratinocytes 9. More importantly, it has been found that
keratinocytes can produce cytokines, that drives immune response, as well as many other
growth factors which are all essential for maintaining the natural homeostasis 10. What
we mean to say is that keratinocytes have a pivotal role playing as a physical barrier and
immune response inducer against invaders.
When Herpes Simplex Virus Type 1(HSV-1) encounters the host cell, it may utilize both
endocytosis and fusion within the plasma membrane pathways by binding to the HveC
gD receptor which is also known as nectin-1; suppression of this receptor leads to
reduction of the HSV-1 entry on murine keratinocytes 11. The importance of the nectin-1
receptor that mediates the HSV-1 entry has been reported in many studies. The
glycoprotein D (gD) facilitates the HSV-1 entry by interacting with the nectin-1 receptor
on the host cells 12. In addition to the nectin-1 receptor, there are many receptors
involving virus entry into a host cell, including herpesvirus entry mediator (HVEM) and
3-O-sulfated heparan sulfate (HS) which interact with glycoproteins gB, gH, and gL 6.
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The Role of Macrophages During HSV-1 Infection:
Macrophages are derived from monocytes, and they play important roles in regulating the
innate immune response during inflammation and infection. Hence, macrophages present
and emigrate within the bloodstream, and some of them reside in tissues 13. During infection,
macrophages play critical roles in homeostasis, tissue repair, and inducing immune response.
Thus, macrophages are found almost all over the body, and they act as phagocytic cells
which engulf and kill invaders and foreign substances 14. While in the HSV-1infection, the
virus binds to macrophage utilizing the toll-like receptor (TLR) and activates the myeloid
differentiation primary response 88 (MyD88) signaling the pathway leading to the production
of pro-inflammatory cytokines such as anti-viral interferon; in addition, macrophages can
eliminate the HSV-1 infection in various ways that includes the production of reactive
oxygen species (ROS) and nitric oxide (NO) 15.

In this study, the PAM-212 murine keratinocytes and RAW 264.7 macrophage cell line
were selected for studying the role of macrophages in restricting HSV- 1 replication during
infections. The hypothesis of this study was that mimicking the in-vivo immune response
will be induced by macrophage when keratinocytes is infected with HSV-1. The effects of
HSV-1 on cell viability, morphology, and replication at 24, 48, and 72 hours were observed
in each cell types and in co-culture. The RAW 264.7 macrophage cell line would restrict
HSV-1 replication within keratinocytes and clear the infection.

3

Figure 2: This Diagram Illustrates the Main Layers of the Skin. The
epidermis layer is the first layer in the skin and it is composed of several
layers and different types of cells, mainly keratinocytes. The dermis layer is
the next one to the bottom and it consists nerves and blood vessels.
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Figure 3: The Two Different Pathways for Herpes Simplex Virus Type 1 Entry
into the Host Cell: by Direct Fusion within the Plasma Membrane or by the
Endocytosis pathway.
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LITERATURE REVIEW

Herpes Simplex Virus Type 1
The word herpes was taken from Greek ancient language meaning crawl or
creep; after that herpes viruses family was named including Herpes Simplex Virus
Type 1 (HSV-1) and Herpes Simplex Virus Type 2 (HSV-2) which are the most
contagious pathogens in humans 16. Herpes Simplex Virus Type 1 (HSV-1) belongs
to the alphaherpesvirus subfamily, and the virion composed of four main parts
including dsDNA genome (157 kb), teguments, nucleocapsid, and glycoproteins on
the surface of the envelope 17. However, it is known to infect humans and cause
infectious diseases including orofacial and genital herpes 18.
HSV-1 infection is often present in tissues that are enriched in keratinocytes
and nerve endings as a main target to initiate the infection. Therefore, skin, the
mucosa, and the cornea are the primary entry site for the HSV-1 infection in humans
19

. In general, the virus develops two types of infection post the inoculation: primary

and latent infection. Following the primary infection that occurred in the epithelial
cells, the virus undergoes a latency state in ganglion cells and persists for lifelong in
the victim 20. Unfortunately, there is no treatment or vaccine that could prevent
infection or eliminate latency 21.
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Herpes Simplex Virus Type 1 Entry and Infection in Keratinocytes:
HSV-1 utilizes different pathways to target the host cell either by fusion with
the plasma membrane directly or by endocytosis, either pH-dependent or pHindependent 22. The infection starts when the virus encounters the skin or the mucosa
and establishes binding between viral glycoproteins on the envelope and a specific
type of cellular receptors to invade targeted cells on the epithelium 23. The common
receptors on the surface of the host cell that trigger HSV-1 entry are nectin-1, herpes
virus entry mediator HVEM, heparan sulfate (HS), and 3-O-HS. By contrast the
nectin-1 and HVEM have been reported as most involved in HSV infections and
pathogenesis among humans 24.
The event of entry is initiated by binding the viral glycoproteins gB and gC to
heparan sulfates (HS) and paired immunoglobulin-like type 2 receptor alpha (PILRα)
on the surface of the host cell which leads gD binding to nectin-1 or HVEM and
induces conformational changes on gH/gL followed by nucleocapsid fusion within
the host cell plasma membrane to the cytoplasm 25. Thus, the tegument proteins that
protect the nucleocapsid, dissociate and translocate the viral genome into the nucleus
of the host cell, and establish viral immediate-early transcription 26. First, the viral
immediate-early genes transcription and translation includes IE, α, E, and β followed
by viral DNA replication. Then, it binds to infected cell protein 8 (ICP8) which
activates the transcription and the translation of the late genes (L&γ) that were
encoded for the nucleocapsid and the teguments. Eventually, the viral genome will be
packaged in the nucleocapsid and released from the host cell 27-28. Hence, the new
virion is ready to invade other host cells.
7

In a study, it has been confirmed that the pro-inflammatory cytokine INF-β
was produced in the infected epidermis keratinocytes with HSV-1 in both cell culture
and specimens were taken from human patients 29. In contrast, other study suggested
that cell immune response is inhibited when viral genes are expressed that indicates
the role of viral genes to inhibit antiviral response 30. As an example, during the early
phase of the infection, ICP0 is expressed and that may activate viral gene expression
and inhibit type 1 IFN-gene induction resulting in augmentation of infection 31-32. In
addition, ICP0 expression may degrade interferon inducible protein-16 (IFI-16) and
inhibits interferon regulatory factor-3 (IRF-3) signaling and prevents IFN type 1
induction 32.
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The Role of Innate Immune System During HSV-1 Infection:
The immune system is the first line of defense in the body against pathogens
and foreign substances. There are many types of immune cells involved in this duty
including natural killer (NK), dendritic cells (DC), neutrophils, and macrophages;
however, all these cell types participate in restricting HSV-1 invasion. Moreover, T
lymphocytes including both CD4+ and CD8+ are important to produce type 1 IFN for
inhibiting the HSV-1 infection and replication 33. In contrast, HSV-1 has multiple
pathways to impair anti-viral productions such as interfering with IFN expressions
and functions 34.
However, the macrophages are immune cells derived from monocytes that
originated from the bone marrow and migrate through the blood stream 35.
Eventually, they reside in different tissues and have different names. Hence, they play
pivotal roles to protect the body from pathogens, to maintain homeostasis, to involve
in damage repair, and to engulf foreign substances. Furthermore, these immune cells
induce immune responses by secreting pro-inflammatory cytokines, chemokines, and
tumor necrosis factors 36. Thus, macrophages sense the danger signals via Toll-like
receptors (TLRs), pattern recognition receptor (PRRs), and interleukin-1 receptor (IL1R) and establish the MyD88 signaling pathway 13. This binding results in proinflammatory cytokines as anti-viral production including IFN α/β, TNF, and IL-12.
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Herpes Simplex Virus Type 1 (HSV-1) immune evasion strategies
The HSV-1 has multiple mechanisms to escape immune recognition and
maintain virus replication by inhibiting innate immune cells and epithelial cells of
immediate immune response soon after invasion as well as inhibiting cellular
translation and programed cell death 37. Moreover, it can interfere with the major
histocompatibility complex class 1 (MHC I), complement activation, down-regulate
Fc receptor, and prevent apoptosis in host cell; in addition, the HSV-1 has the ability
to inhibit MHC II expression on macrophages which leads to a reduction of cytokines
production by natural killer cells (NK) and T lymphocytes 38.
Likewise, the HSV-1 infected keratinocytes inhibit the pro-inflammatory
cytokines such as interleukin-1β (IL-1β), and block interferon IFNs’ functions 34. By
contrast HSV-1 infected keratinocytes continue to produce the interleukin-1α (IL-1α)
which is important for recruiting white blood cells to the site of infection and
preventing viral replication. The IL-1β shows high expression in macrophages;
however, both of IL-1α and IL-1β have same cellular receptor which is IL-1 receptor
type 1(IL-1R) 39. The role of IL-1α has been demonstrated for immune cells
recruitment by blocking IL-1R which lead to a significant decrease in neutrophil
influx in mice 40.

10

MATERIALS AND METHODS
Three different cell lines and (HSV-1) virion were utilized on two models of cell
culture (monolayer and co-culture system) in this study.
PAM212 is a keratinocyte cell line derived from newborn BALB/c mice and was
previously obtained from Joanna Anders at NIH/NCI. The RAW 264.7 murine
macrophage cell line is derived from a tumor induced by Abelson murine leukemia virus
obtained from an adult male BALB/c mouse. Both are adherent cell lines by nature. They
were initially thawed and seeded individually in T-25 (25 cm2) culture flasks, and then
transferred to T-75 (75 cm2) culture flasks for maintenance and cell splitting.
Each monolayer was grown in the presence of Dulbecco's Modified Eagle Medium
(DMEM) (Fisher Science, Pittsburgh, PA) supplemented with 10% heat inactivated fetal
bovine serum (FBS).
HSV-1 (syn17+) (initially provided by Dr. Nancy Sawtell, Children’s Hospital
Medical Center, Cincinnati, OH), was utilized for infection. Prior to infection, a Plaque
Assay was performed to determine the virus titers in the original stock by utilizing Vero
cells line (CCL-81, American Type Culture Collection) developed from African green
monkey kidney epithelial cells. The PFU/ml for the virus in original stock was 6.8 X 107
viral particles per ml. Therefore, 0.44 µl or 0.22 µl of virus stock was added to 1000 µl
media supplemented with 1% FBS per well for infection. In this study, 6-well plates were
used for the cell infection and the Plaque Assay throughout the experiments. Cell cultures
were incubated in a humidified incubator at 37° C, 5% CO2.

11

Infection Protocol for Keratinocytes (PAM-212):
The keratinocytes (PAM-212) were seeded in 6-well plates at density of 3 X
105 cells per well. Each well was supplied with 3 ml medium containing 10 % FBS
and incubated overnight for cell adhesion. At 70% of cell confluence, old medium
was discarded and washed with 2 ml of PBS prior infection. In each well, 1 ml of a
new medium supplemented with 1% FBS was added. Hence, a volume of 0.44 µl was
taken from the (HSV-1) original stock to infect three wells at multiplicity of infection
(MOI) 0.1 ratio 1:10 while the remaining three uninfected wells were used as a
negative control. Then cell cultures were incubated for 2 hours to establish the
infection. In the next step, the virus was removed, cell cultures were washed with 2
ml of PBS per well, and 3 ml of fresh medium supplemented with 10% FBS was
added. Again, cell cultures were incubated at 37 Co and 5% Co2 for 24, 48, and 72
hours after the infection. After the incubation period, the suspension was collected
from the 6-well plates individually in 15 ml centrifuge tubes and centrifuged at 1600
(rpm); 4 Co for 5 minutes. 1000 µl of the supernatant from each tube was transferred
to the 1.5 ml centrifuge tubes and stored at – 80 Co for plaque assay. The 15 ml
centrifuge tubes that were used previously were reused to collect cells after
trypsinization and centrifuged at 1600 (rpm); 4 Co for 5 minutes to form a pallet in the
bottom of the tubes. The supernatant obtained after trypsinization was aspirated, and
the pellet was resuspended in 1 ml of 10% FBS medium for calculating the cell
viability.
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Infection Protocol for Unpolarized Macrophages (RAW 264.7):
Unpolarized macrophages (RAW 264.7/ M0) were seeded in 6-well plates at density
of 3 X 105 cells per well. 3 ml of media supplemented with 10 % FBS was added to each
well and incubated for cell attachment. After cell adhesion, old medium was removed and
washed with 2 ml of PBS prior infection. In each well, 1 ml of a new medium
supplemented with 1% FBS was added. After that, a volume of 0.44 µl was taken from
the (HSV-1) original stock to infect three wells at multiplicity of infection (MOI) 0.1
ratio 1:10 while the remaining three uninfected wells used as a negative control. Then the
plates were incubated for 2 hours to establish the infection. In the following step, the
virus was removed, cell cultures were washed twice with 2 ml of PBS, and 3 ml of fresh
medium contained 10% FBS was added. After that, cell cultures were incubated at 37 Co
and 5% Co2 for 24, 48, and 72 hours post-infection. Following the incubation time, cells
were detached form 6-well plates by utilizing cell scraper (Thermo-Fisher Scientific
Brand). The suspension was collected from each well individually in 15 ml centrifuge
tubes and centrifuged at 1600 (rpm); 4 Co for 5 minutes. 1000 µl of each supernatant was
transferred to the 1.5 ml Eppendorf tubes and stored at – 80 Co for plaque assay. The
pellet in the bottom of the tubes remained intact when the supernatant was taken. The
remaining of supernatant was aspirated, and the pellet was resuspended in 1 ml of 10%
FBS media for calculating the cell viability.
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Infection Protocol for Co-culture (PAM-212& RAW 264.7):
First, keratinocytes (PAM-212) were seeded in 6-well plates at density of 1.5 X
105 cells per well. Each well was supplied with 3 ml medium containing 10 % FBS
and incubated overnight for cell adhesion. After cell adhesion, old medium was
removed and washed with 2 ml of PBS prior infection. In each well, 1 ml of a new
medium supplemented with 1% FBS was added. After that, a volume of 0.22 µl was
taken from the (HSV-1) original stock to infect three wells at multiplicity of infection
(MOI) 0.1 ratio 1:10 while the remaining three uninfected wells were used as a
negative control. Then the plates were incubated for 2 hours to initiate cell infection.
In the following step, the virus was removed, cell cultures were washed with 2 ml of
PBS, and 3 ml of fresh media containing 10% FBS was added. Second, unpolarized
macrophages were added at ratio 1:5 of keratinocytes 1. Thus 3 X 104 cells of M0
macrophages (RAW264.7) were added to the 1.5 X 105 cells of keratinocytes (PAM212) previously seeded and infected with HSV-1 in 6-well plates. After that, cell
cultures were incubated at 37 Co and 5% CO2 for 24, 48, and 72 hours post-infection.
Following the incubation period, the suspension was collected from each well
individually in 15 ml centrifuge tubes and centrifuged at 1600 (rpm); 4 Co for 5
minutes. 1000 µl of the supernatant of each was transferred to the 1.5 ml Eppendorf
tubes and stored at – 80 o C for plaque assay. The 15 ml centrifuge tubes that were
used previously, were reused again to collect cells after trypsinization and centrifuged
at 1600 (rpm); 4 Co for 5 minutes to form a pallet in the bottom of the tubes. The
supernatant obtained after trypsinization was aspirated, and the pellet was
resuspended in 1 ml of 10% FBS media for calculating the cell viability.
14

Cell Viability:
Trypan Blue Exclusion Test was used to determine the cell viability which indicates
the percentages of viable and non-viable cells in the suspension obtained from cell
culture. It requires a sample of suspension, hemocytometer, trypan blue stain (Fisher
Scientific, Pittsburgh, PA brand), coverslips, micropipettes (P1000, P200, and P20), blue
and yellow tips, and light microscope. First, the sample of suspension was obtained by
scraping and/or trypsinization as described previously. The suspension was collected in
15 ml centrifuge tubes and centrifuged at 1600 (rpm); 4 Co for 5 minutes to form a pellet
in the bottom of the tubes. The supernatant was aspirated, and the pellet was resuspended
in 1 ml of 10% FBS media. Second, cells were mixed well utilizing a micropipette
(P1000). Then, 100 µl of trypan blue stain and 50 µl of the suspension were transferred
via micropipette (P200) to 1.5 ml Eppendorf tube and mixed genially. Third, 10 µl was
taken by micropipette (P20) form the blend and placed on the hemocytometer initially
covered with coverslip. Fourth, the hemocytometer was examined under the 10x
magnification power in the light microscope. Finally, cells were counted, viable cells
were remained unstained while non-viable cells were stained blue.
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Figure 4: Trypan Blue Exclusion Test utilizing hemocytometer.
Under the light microscope lens at 10x magnification power, cells were counted. Each
circular dot represents cell. The bright dots represent viable cells while the dark once
represent non-viable cells. L shaped arrow shows pathway how cells were counted.
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Plaque Assay:
The plaque assay measures infectious virus particles contained in a stock. Thus,
plaque formation means the virus was able to initiate infection, propagate and display
cytopathic effect (CPF) on cell culture. The plaques can be counted and visualized by the
naked eye after staining the plate with 1% of crystal violet as colorless spots. Therefore,
virus titers were calculated based on the plaque forming units per ml (PFU/ml).
Herpes Simplex Virus-1 strain Syn 17+ was previously obtained from (Dr. Nancy
Sawtell, Children’s Hospital Medical Center, Cincinnati, OH). Prior to utilizing HSV in
this study for infection, virus titers were determined. Plaque assay was performed on
Vero cells at 100% confluency. Initially, Vero cells were seeded in 6-well plates at
density of 3 X 105 cells per well. 3 ml of media supplemented with 10 % FBS was added
to each well. Vero cells usually reach 100% confluency within 2-3 days. Before
infection, a serial dilution for original stock is required (Figure 4). First, 10 - 1.5 ml
centrifuge tubes were set on a rack and labeled from -1 to -10 as a dilution factor. Then
900 µl of DMEM without FBS was added to each tube. A 100 µl of virus stock was
transferred to the first tube. Next, 100 µl was taken from tube -1 to tube -2, this process
continued to the last tube -10. After that, old medium was removed from Vero cells
culture and washed with 2 ml of PBS prior infection. To infect cells, 500 µl of diluted
virus was added to each well. The first well of 6-well plates was used as a negative
control. Then, the plates were incubated for 1 hour to establish the infection. In the
following step, the virus was removed, cell cultures were washed once with 2 ml of PBS
and covered with 3 ml of 4% methyl-cellulose. Next, plates were incubated at 37 Co and
5% Co2. The plaques were usually seen after 3-5 days. After the plaques were formed, 3
17

ml of 4% paraformaldehyde was added for fixation. Plates were incubated at room
temperature for 1 hour. Then agarose and paraformaldehyde were removed and washed
gently with tap water. About 2 ml of 1% crystal violet solution (Sigma) was added and
incubated at room temperature for 5-10 minutes. Stain was removed with tap water, and
plaques were counted as followed.
number of plaques

PFU/ml (of original stock) = dilution factor x (ml on inoculum /plate)

Figure 5: Serial Dilution Method for Plaque Assay.
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Statistical Analysis
Data were obtained from conducting triplicates within all experiments in this
study. Sigma-Plot 12.0 software; One-Way ANOVA, was utilized for analyzing data
and calculating statistical significance. Outcomes were compared for the P-values,
any data showing ≤ 0.05 were considered as statistically significant.

Symbol

Meaning

ns

P > 0.05

*

P ≤ 0.05

**

P ≤ 0.01

***

P ≤ 0.001

Table 1: Symbol Representation and Meaning for Indicating the Statistical
Difference.
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RESULTS
Cell Viability:
The Cell Viability of Uninfected and Infected Keratinocytes (PAM-212) with HSV1 after 24, 48, and 72 Hours.
Keratinocytes were either uninfected (control) or infected with herpes simplex
virus type 1 at multiplicity of infection (MOI) 0.1. Cell viability was determined after
24, 48, 72 hours by performing Trypan Blue Exclusion Test. In all experiments
exhibited significant decrease in cell viability at 24, 48, and 72 hours post infection.
Keratinocytes exhibited slightly significant decrease (~6.5%, P-value = 0.001) in cell
viability following infection with HSV-1 compared to control at 24 hours. Also, a
significant decrease in viability was observed in keratinocytes (~16.6%, P-value = <
0.001) following infection at 48 hours. However, after 72 hours of infection there was
a strongly significant decrease in cell viability about (~46.7%, P-value = <0.001). In
contrast, there was no significant difference between in infected keratinocytes at 24
and 48 hours (P-value = 0.055). In contrast, keratinocytes infected with HSV-1 at 72
hours showed significant decrease in cell viability compared to 24 and 48 hours (Pvalue = <0.001, P-value = <0.001) respectively (Figure 6).
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The Cell Viability of Uninfected and Infected Macrophages (RAW 264.7) with
HSV-1 after 24, 48, and 72 Hours.
Macrophages were either uninfected (control) or infected with herpes simplex
virus type 1 at multiplicity of infection (MOI) 0.1. Cell viability was counted after 24,
48, and 72 hours by utilizing Trypan Blue Exclusion Test. There was no statistically
significant difference in cell viability at 24 post infection (~1%, P-value = 0.439). At
48 and 72 hours following infection, macrophages exhibited a large significant
decrease in cell viability (~8.1%, 46.3%, P-value = <0.001, P-value = <0.001),
respectively, compared to control. There was significant difference between infected
macrophages at 24 and 48 hours (~5.3 %, P-value = 0.033). In contrast, at 72 hours
macrophages infected with HSV-1 showed significant decrease in cell viability
compared to 24 and 48 hours (~44.8%, ~39.5%, P-value = <0.001, P-value = <0.001)
respectively (Figure 7).
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The Cell Viability of Uninfected and Infected Co-culture (RAW 264.7 & PAM-212)
with HSV-1 after 24, 48, and 72 Hours.
In the co-culture model, keratinocytes were first either infected with HSV-1 or
uninfected as a negative control at multiplicity of infection (MOI) 0.1 and incubated
for 2 hours, then the macrophages were added at ratio of 1:5 and incubated for timepoints. Cell viability was examined after 24, 48, and 72 hours by utilizing Trypan Blue
Exclusion Test. They exhibited a slightly significant difference in cell viability at 24
post infection (~1% (*) P-value = 0.026). While at 48 and 72 hours following infection,
co-cultured cell lines exhibited a large significant decrease in cell viability (~36.3%,
64.6%, P-value = <0.001, P-value = <0.001), respectively compared to the control.
However; in comparison to the different of time-points, there was a significant
difference between infected co-cultured cell lines at 24, 48 and 72 hours (P-value =
<0.001, P-value = <0.001, and P-value = <0.001) respectively (Figure 8).
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The Cell Viability compared between all Cell Lines (RAW 264.7, PAM-212, and
Co-culture) Uninfected and Infected with HSV-1 after 24 Hours.
The cell viability was tested for all cell lines (RAW 264.7/M0 & PAM-212) in
monolayers and co-culture model, after they were infected with herpes simplex virus
type 1 at multiplicity of infection (MOI) 0.1 and incubation time for 24 hours. The
cell lines were either infected with HSV-1 or uninfected as a negative control. Cell
viability was examined after 24 hours by utilizing Trypan Blue Exclusion Test. The
keratinocytes (PAM-212) monolayer exhibited a significant reduction in cell viability
at 24 post infection (~6.5%, P-value = 0.001). The macrophage (RAW 264.7)
monolayer showed no significant difference at 24 hours following infection. By
contrast the co-cultured cell lines exhibited a little significant decrease in cell viability
(~1%, P-value = 0.026) compared to the control. However, in comparison between
the co-cultured cell lines versus the different monolayers cell line, it showed a
significant increase in cell viability at 24 hours (~7.7%, 7.5%; P-value = <0.001, Pvalue = <0.001) respectively. There was no significant difference between the
keratinocytes and macrophages M0 monolayers (~ 0.002%, P-value = 0.920) (Figure
9).
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The Cell Viability compared between all Cell Lines (RAW 264.7/M0, PAM-212,
and Co-culture) Uninfected and Infected with HSV-1 after 48 Hours.
The cell viability was tested for all cell lines (RAW 264.7/M0 & PAM-212) in
monolayers and co-culture model, after they were infected with herpes simplex virus
type 1 at multiplicity of infection (MOI) 0.1 and incubated for 48 hours. The cell lines
were either infected with HSV-1 or uninfected as a negative control. Cell viability
was examined after 48 hours by utilizing Trypan Blue Exclusion Test. All monolayers
and co-cultured cell lines (PAM-212, RAW 264.7/M0, and Co-culture) exhibited a
significant decrease in cell viability at 48 post infection (~16.6%, 8.1%, & 36.3%; Pvalue = <0.001 P-value = <0.001, P-value = <0.001) respectively were compared to
control. However; in comparison between the different of cell lines, there was no
significant difference between the keratinocyte and macrophage monolayers infected
groups (~5.1 %, P-value = 0.282) while the co-cultured cell lines infected group
showed a great significant decrease in cell viability at 48 hours (~19 %, 24.1%; Pvalue = <0.001, P-value = <0.001) compared to (PAM-212 & RAW 264.7/M0)
respectively (Figure 10).
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The Cell Viability compared between all Cell Lines (RAW 264.7, PAM-212, and
Co-culture) Uninfected and Infected with HSV-1 after 72 Hours.
The cell viability was tested for all cell lines (RAW 264.7/M0 & PAM-212) in
monolayers and co-culture model, after they were infected with herpes simplex virus
type 1 at multiplicity of infection (MOI) 0.1 and incubated for 72 hours. The cell lines
were either infected with HSV-1 or uninfected as a negative control. Cell viability
was examined after 72 hours by utilizing Trypan Blue Exclusion Test. All monolayers
and co-cultured cell lines (PAM-212, RAW 264.7/M0, and Co-culture) exhibited a
great significant decrease in cell viability at 72 post infection (~46.7%, 46.3%, &
64.6%; P-value = <0.001 P-value = <0.001, P-value = <0.001) respectively. However,
there was no significant difference between the keratinocytes and macrophages M0
monolayers infected groups (~6.1%, P-value = 0.323) while the co-cultured cell lines
infected group showed a great significant decrease in cell viability at 72 hours (~26.7
%, 20.6%; P-value = <0.001, P-value = 0.003) compared to (PAM-212 & RAW
264.7) respectively (Figure 11).
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Herpes Simplex Virus Type1 Cytopathic Effect (CPE):
All cell lines (PAM-212, RAW 264.7, and co-culture) were seeded, maintained,
and infected on 6-well plates. In each plate, three wells were infected with HSV-1 and
the three remaining were used as a negative control. Post-infection, plates were
incubated at 37Co, 5% Co2, for 24, 48, and 72 hours. The HSV-1 cytopathic effect
(CPE) was evident in all infected groups during incubation time-points. After 24
hours of infection, some of cells appeared enlarged in size, irregularly shaped, and
some were floating in the medium, that indicates cell lysis and HSV-1 cytopathic
effect. At 48 post-infection, same signs were observed, but in higher percentages.
Furthermore, at 72 hours post-infection cell were mostly detached and more debris
were visible. The HSV-1 cytopathic effect (CPE) on Vero cell was clear prior to
plaque formation (Figure 12).
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Plaque Assay:
Plaque assay was utilized to calculate HSV-1 concentrations in different samples
were collected from different experiments and stored at – 80 Co. Therefore, Plaque
assay was performed in triplicate on 6-well plates, and each single assay represents
different samples within experiment. The supernatant that used for plaque assay was
obtained from keratinocytes (PAM-212), macrophages (M0), and (PAM-212 and M0)
co-cultured cell lines post-infected them with HSV-1 at 24, 48, and 72 hours. Plaques
formation were evident at different serial dilution factors (SDFs) from 10-1 to 10-10.

The Plaque Assay for Keratinocytes (PAM-212) Infected with HSV-1 at 24, 48, and
72 Hours.
In keratinocytes (PAM-212) at 24 hours, plaques formation was observed from
10-1 to 10-5. However, the virus titers were counted at x10-3, and the plaque formed
per ml (PFU/ml) was 12.6 X 10-3 in average. At 48 hours, plaques formation was
observed from 10-1 to 10-10. The virus titers were counted at x10-8, and the plaque
formed per ml (PFU/ml) was 214 X 10-8 in average. While at 72 hours, plaques
formation was observed from 10-1 to 10-10. The virus titers were counted at x10-8, and
the plaque formed per ml (PFU/ml) was 224 X 10-8 in average. On the other hand,
HSV-1 titers were significantly increased in the keratinocytes from 24 to 48 and 72
hours respectively. In contrast, there was no significant difference between virion
replication at 48 and 72 hours (Figure 13).
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The Plaque Assay for Macrophages (RAW 264.7 / M0) Infected with HSV-1 at 24,
48, and 72 Hours.
In macrophages (RAW 264.7/ M0) at 24 hours, plaque formation was observed
from 10-1 to 10-5. However, the virus titers were counted at x10-3, and the plaque
formed per ml (PFU/ml) was 65.6 X 10-3 in average. At 48 hours, plaques formation
was only observed from 10-1 to 10-5 and there were no plaques formation beyond the
dilution factor x10-5 as was demonstrated by six trials. The virus titers were counted
at x10-2, and the plaque formed per ml (PFU/ml) was 132 X 10-2 in average. While at
72 hours, plaques formation was observed from 10-1 to 10-10. The virus titers were
counted at x10-8, and the plaque formed per ml (PFU/ml) was 91 X 10-8 in average.
Moreover, HSV-1 titers were remarkably decreased in the macrophages from 24 to 48
hours. However, there was a large significant increase in virion titers at 72 hours
compared to 24 and 48 hours (Figure 14).
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The Plaque Assay for Co-culture (PAM-212 + M0) Infected with HSV-1 at 24, 48,
and 72 Hours.
In co-culture model (PAM-212 + RAW 264.7/M0) at 24 hours, plaque formation
was observed only at 10-1 in one plate while other plate did not show any plaque
formation beyond the dilution factor x10-1 as was demonstrated by four trials.
However, the virus titers were counted at x10-1, and the plaque formed per ml
(PFU/ml) was 55.3 X 10-1 in average. At 48 hours, plaque formation was observed
from 10-1 to 10-10. The virus titers were counted at x10-8, and the plaque formed per
ml (PFU/ml) was 34.6 X 10-8 in average. While at 72 hours, plaques formation was
observed from 10-1 to 10-10. The virus titers were counted at x10-8, and the plaque
formed per ml (PFU/ml) was 91.3 X 10-8 in average. However, HSV-1 titers were
noticeably decreased in the co-culture model at 24 compared to virus titers at 48 and
72 hours respectively. Nevertheless, there was a slight difference between virion
concentrations at 48 and 72 hours (Figure 15).
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Keratinocytes

Macrophages

Co-culture Model

(PAM-212)

(RAW 264.7)

(PAM-212 + RAW 264.7)

PFU/ml

PFU/ml

PFU/ml

24 Hours

12.6 X 10-3

65.6 X 10-3

55.3 X 10-1

48 Hours

214 X 10-8

132 X 10-2

34.6 X 10-8

72 Hours

224 X 10-8

91 X 10-8

91.3 X 10-8

Time / Cell Lines

Table 2: This table illustrates Plaque Forming Units Per ml (PFU/ml) for Herpes Simplex
Virus Type 1 Obtained by Plaque Assay.
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The Plaque Assay compared between all Cell Lines (RAW 264.7, PAM-212, and
Co-culture) Infected with HSV-1 after 24 Hours.
The plaque assay was performed for all the infected cell lines (RAW 264.7/M0 &
PAM-212) in monolayers and co-culture model. Then, the HSV-1 titers were
compared for 24 hours. The keratinocytes (PAM-212) monolayer exhibited less
significant virus concentration compared with macrophages at 24 hours (~5.1fold, Pvalue = <0.001). The macrophage (RAW 264.7 /M0) monolayer showed the most
significant increase in HSV-1 replication at 24 hours compared to keratinocytes and
co-culture (~5.1 fold, 118 fold, P-value = <0.001, P-value = <0.001) respectively. On
the other hand, the co-cultured cell lines (PAM-212 + RAW 264.7/M0) exhibited the
lowest significant in virion titers compared to the monolayers infected groups at 24
hours (~22.7 fold, 118 fold, P-value = <0.001, P-value = <0.001) respectively (Figure
16).
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The Plaque Assay compared between all Cell Lines (RAW 264.7, PAM-212, and
Co-culture) Infected with HSV-1 after 48 Hours.
The plaque assay was performed for all the infected cell lines (RAW 264.7/M0 &
PAM-212) in monolayers and co-culture model. Then, the HSV-1 titers were
compared for 48 hours. The keratinocytes (PAM-212) monolayer exhibited no
significant in virus concentration compared with co-culture at 48 hours (~1.5 fold, Pvalue = 0.078). While the macrophages (RAW 264.7 /M0) monolayer showed the
lowest significant in HSV-1 replication at 48 hours compared to keratinocytes and coculture (~1.65X106 fold, 1.11X106 fold, P-value = 0.008, P-value = 0.012)
respectively (Figure 17).

The Plaque Assay compared between all Cell Lines (RAW 264.7, PAM-212, and
Co-culture) Infected with HSV-1 after 72 Hours.
The plaque assay was performed for all the infected cell lines (RAW 264.7/M0 &
PAM-212) in monolayers and co-culture model. Then, the HSV-1 titers were
compared for 72 hours. The keratinocytes (PAM-212) monolayer exhibited a
significant increase in virus concentration compared with macrophages (M0) and coculture at 72 hours (~5.6 fold, 2.44 fold, P-value = <0.001, P-value = <0.001). While
the macrophages (RAW 264.7 /M0) monolayer showed the less significant in HSV-1
replication at 72 hours compared to keratinocytes and co-culture (~5.6 fold, 2.3 fold,
P-value = <0.001, P-value 0.052) respectively (Figure 18).
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DISCUSSION
The goal of this study was to develop a new model of cell co-culture that
could illustrate the role of the macrophages (RAW 264.7) in responding to Herpes
Simplex Virus Type 1 (HSV-1) within infected keratinocytes. For this purpose, we
used macrophages (RAW 264.7) and murine keratinocytes (PAM-212) to investigate
the susceptibility of each cell line in monolayer to the HSV-1 infection. In the next
step, we started to infect the keratinocytes with HSV-1 for two hours at the
multiplicity of infection (MOI) 0.1. Then the virus was removed, and the cell culture
was washed with PBS prior to co-culturing them with the macrophages at ratio “1:5”
1

for time-points of 24, 48, and 72 hours. In this study, we just focused on the

cytopathic effect (CPE), cell viability, and plaque assay.
Interestingly, we found that there were some differences and similarities
between keratinocytes (PAM-212) and macrophages (RAW 264.7) in all the models
that we used in this study. We observed some morphology changes that were a result
of the HSV-1 invasion to the host cells after 24, 48, and 72 hours. These morphology
changes illustrate the cytopathic effects (CPE) of the HSV-1 infection. However, the
different cell lines that we utilized in this project exhibited almost the same
morphology changes in the earlier phase of the infection at 24 and 48 hours. The
infected cells appeared either irregularly shaped or rounded cells, enlarged in size,
and seemed in different density compared to the surrounding area. In contrast, at 72
hours cells were degraded and detached, and there was more debris in the medium in
the keratinocytes monolayer. The macrophage monolayers and the co-culture were
similar to keratinocytes except the medium was clearer with less debris (Figure 12).
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We attributed the clearance of debris in the medium to the macrophages’ ability to
engulf and digest the foreign substance. Same signs of cytopathic effects have been
observed in vitro on the infected epithelium and described as “a reticular degeneration
and ballooning of the cells as well as the appearance of large irregular or
multinucleated giant cells” 41-42.
Our results suggest that the PAM-212 and RAW 264.7 cell lines were
susceptible to the HSV-1 infection and replication within the observation time-points
of 24, 48, and 72 hours. In spite of the fact that macrophages are more likely to play
pivotal role in preventing the HSV-1 infection, they were found also to be susceptible
to the virus replication 35.
The results of the cell viabilities were significantly decreased in the
keratinocytes PAM-212 monolayer infected with HSV-1 at 24 hours, while the
infected macrophages showed no significant difference in cell viability at 24 hours
post-infection. That shows both PAM-212 and RAW 264.7 susceptible to the virion.
On the other hand, in the co-culture model there was a noticeable increase in cell
viability of the PAM-212 keratinocytes at 24 hours. Since the macrophages were
added two hours later to the infected PAM-212, they response to the stimuli produced
from the infected keratinocytes. That suggests the role of macrophages in preventing
pathogens invasion in the body and in the co-culture model.
Surprisingly, at 24 hours post-infection our results of the plaque assay show a
significant increase in the virus concentration (~5.1 fold, P-value = <0.001) in the
macrophages supernatant compared to the PAM-212 which exhibited less virus titers
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that suggests the ability of HSV-1 to suppress the immune response at an early phase
of the infection (Figure 16). These results are in agreement to what has been reported
in the ability of the HSV-1 to manipulate the immune invasion strategies to maintain
virus replication in epithelial cells and innate immune cells 37.
In our co-culture model, we assumed that the role of macrophages that restrict
HSV-1 dissemination. Our results demonstrate a remarkable decrease in the virus
PFU/ml in this model at the first 24 hours compared to the keratinocytes and the
macrophages monolayers (~22.7 fold, 118 fold, P-value = <0.001, P-value = <0.001)
respectively (Figure 16). Therefore, we attribute that to the immune response of RAW
264.7 macrophages to virus released from the keratinocytes infected with the HSV-1
two hours prior to the addition of macrophages at ratio 1:5 (macrophages :
keratinocytes). Thus, we think that the cytokines which were produced from infected
cells such as INF-α/β, IL-1α, TNF, and reactive oxygen species (ROS) activate the
macrophage and guide them toward the site of infection. Moreover, it has been
reported that the interleukin-1β was inhibited by the HSV-1 infection and block IFNs’
function; on the other hand, the interleukin-1α is released from the host cell, and that
plays role in recruiting leucocytes to the site of infection by expressing the IL-1
receptor type 1(IL-1R1) which is the same in both the epithelial cells and
macrophages 30-35. Therefore, we attribute the increase of cell viability and the
decrease of virus titers at 24 hours in co-culture to the stimulus which could be IL-1α.
However, the cell viability was significantly decreased in the PAM-212 and
macrophages monolayer, and the co-culture model infected with HSV-1at 48 hours
post-infection. There was no significant difference in cell viability between the
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infected groups in RAW 264.7 and PAM-212 at 48 hours post-infection compared to
the co-culture (Figure 11). We think that the decrease in macrophage cell viability
due to the increase of pro-inflammatory cytokines production such as TNF-α which is
known by its cytotoxicity to the cells, but it plays role in immune response against
invaders. Also, in the co-culture model was decreased in cell viability due to the
duration of exposure to the virus.
In the plaque assay result at 48 hours post the HSV-1 infection, the
macrophages monolayer showed a sharp decrease in the virus titers compared to the
keratinocytes which increase the virion concentration that counted on the plaque
forming units per ml. Our results suggest that the macrophages monolayer was able to
induce an immune response and restrict the HSV-1 replication during the incubation
period of 48 hours compared to 24 hours (~ 4.9 fold, P-value = <0.001) (Figure 14).
In contrast, the keratinocyte monolayer and co-culture exhibited a significant increase
in the virus progeny (~1.65X106 fold, 1.11X106 fold, P-value = 0.008, P-value =
0.012) respectively (Figure 17).
Our experiment outcomes show a significant decrease the cell viability in the
PAM-212 and macrophages monolayer, and the co-culture model infected with HSV1at 72 hours post-infection, but however, there was no significant difference in cell
viability between the infected groups in RAW 264.7 and PAM-212 at 72 hours postinfection compared to the co-culture (Figure 11). We think that the decrease in cell
viability in all cell line models due to many factors includes the increase of cytokines
cytotoxicity, the increase in virus titers, the duration of exposure, and/or macrophages
depletion especially in the co-culture model.
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Finally, we have noticed in the plaque assay results that the macrophages were
unable to withstand with the virus replication at 72 hours. That may be due to the
increase of pro-inflammatory cytokines level such as TNF-α which is known by its
cytotoxicity to the cells as a response to the infection. Therefore, the macrophages
were depleted, and their function was impaired that permitted the virus dissemination.
However, in our results of the macrophages still show a decrease in the virus titers
compared to the keratinocytes monolayer and there was no significant difference
between the virus concentration in the macrophages and the co-culture at 72 hours
(~5.6 fold, 2.3 fold, P-value = <0.001, P-value = 0.052) respectively (Figure 18).
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Future Studies:
In a real-life situation, macrophages along with other innate immune cells would
should restrict HSV-1 invasion by induction of antiviral response. This in vitro co-culture
study system does not permit infiltration of immune cells such as neutrophils, dendritic
cells (DC), and macrophages, a limitation of the study. Further studies in understanding
the immune response of macrophages (RAW 264.7) to HSV-1 infected keratinocytes
(PAM-212) would include identification of the cytokines and other molecules involved,
especially IFN-α/β, TNF-α, IL1-α/β, IL- 10, and ROS. In addition, this co-culture model
could be altered to simulate the effect of macrophages infiltration by adding additional
macrophages at ratio 1:5 or 2:5 (macrophages to keratinocytes) two hours after initiating
co-culture. Another way to alter the co-culture system is to enhance virus clearance by
adding M1 macrophages at 2 hours after initiation of co-culture; this should enhance the
anti-viral effect of IFN-β and other ant-viral macrophage products in the system.
The results from this co-culture system showed a significant increase in cell viability
and a noticeable decrease in HSV-1 titers at 24 hours suggest a role of IL-1α and early
production of IFN-β. Presumably, the IL-1α produced by the keratinocytes two hours
after HSV-1 infection stimulates macrophages to produce IFN-β. Because IL-1α is
produced by both macrophages and keratinocytes, blocking IL-1 receptor type 1(IL-1R)
with specific antibody should interfere with production of antiviral IFN-β and allow
greater virus production. Based on this conjecture, a mixture of IFN-β and IL-1α may be
considered as a potential therapy for herpes simplex virus Type 1 (HSV-1) infection.
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A

Figures

Figure 6: Cell Viability obtained by Trypan Blue Exclusion Test utilizing
hemocytometer for Keratinocytes (PAM-212) after 24, 48, and 72 hours.
Keratinocytes exhibited slightly significant decrease (~6.5%, P-value = 0.001) in cell
viability following infection with HSV-1 compared to control at 24 hours. Also, a
significant decrease in viability was observed in keratinocytes (~16.6%, P-value = < 0.001)
following infection at 48 hours. However, after 72 hours of infection there was a great
significant decrease in cell viability about (~46.7%, P-value = <0.001). By comparison to
the different of all time-periods, there was no significant difference between in infected
keratinocytes at 24 and 48 hours (P-value = 0.055). In contrast, keratinocytes infected with
HSV-1 at 72 hours showed significant decrease in cell viability compared to 24 and 48
hours (P-value = <0.001, P-value = <0.001) respectively. The mean illustrates the
percentages of viable cells and error bars represent standard error ±. The statistics were
obtained utilizing Sigma-Plot 12.0, One-way ANOVA was applied. Stars (*) indicate the
significance level **, p≤ 0.01; ***, p ≤ 0.001, ns = no significant (n= 3).
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Figure 7: Cell Viability obtained by Trypan Blue Exclusion Test utilizing
hemocytometer for Macrophages (RAW 264.7) at 24, 48, and 72 hours.
Macrophages showed no a statistically significant difference in cell viability at 24 post
infection (~1%, P-value = 0.439). While at 48 and 72 hours following infection, macrophages
exhibited a large significant decrease in cell viability (~8.1%, 46.3%, P-value = <0.001, Pvalue = <0.001) respectively compared to control. In comparison to the different of timeperiods, there was significant difference between infected macrophages at 24 and 48 hours
(~5.3 %, P-value = 0.033). In contrast, macrophages infected with HSV-1 at 72 hours showed
significant decrease in cell viability compared to 24 and 48 hours (~44.8%, ~39.5%, P-value
= <0.001, P-value = <0.001) respectively. The mean illustrates the percentages of viable cells
and error bars represent standard error ±. The statistics were obtained utilizing Sigma-Plot
12.0, One-way ANOVA was applied. Stars (*) indicate the significance level, *, P ≤ 0.05,
***, p ≤ 0.001; ns, P > 0.05 = no significance. (n= 3)
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Figure 8: Cell Viability obtained by Trypan Blue Exclusion Test utilizing
hemocytometer for Co-culture (RAW 264.7 PAM-212) at 24, 48, and 72 Hours postinfection with HSV-1.
In the co-culture model exhibited a slightly significant difference in cell viability at 24 post
infection (~1% (*) P-value = 0.026). While at 48 and 72 hours following infection, cocultured cell lines exhibited a large significant decrease in cell viability (~36.3%, 64.6%,
P-value = <0.001, P-value = <0.001) respectively compared to the control. However; in
comparison to the different of time-points, there was a grate significant difference between
in infected co-cultured cell lines at 24, 48 and 72 hours (P-value = <0.001, P-value =
<0.001, and P-value = <0.001) respectively. The mean illustrates the percentages of viable
cells and error bars represent standard error ±. The statistics were obtained utilizing SigmaPlot 12.0, One-way ANOVA was applied. Stars (*) indicate the significance level,*, p ≤
0.05; ***, p ≤ 0.001. (n= 3)
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Figure 9: Cell Viability obtained by Trypan Blue Exclusion Test utilizing
hemocytometer for (RAW 264.7, PAM-212, and Co-culture) at 24 Hours post-infection
with HSV-1.
The keratinocytes (PAM-212) monolayer exhibited a significant reduction in cell viability at
24 post infection (~6.5%, P-value = 0.001). While the macrophages (RAW 264.7 /M0)
monolayer showed no significant difference at 24 hours following infection. Whereas, the cocultured cell lines exhibited a little significant decrease in cell viability (~1%, P-value =
0.026) compared to the control. However, in comparison between the co-cultured cell lines
versus the different monolayers cell line, it showed a grate significant increase in cell viability
at 24 hours (~7.7%, 7.5%; P-value = <0.001, P-value = <0.001) respectively. While there was
no significant difference between the keratinocytes and macrophages M0 monolayers (~
0.002%, P-value = 0.920). The mean illustrates the percentages of viable cells and error bars
represent standard error ±. The statistics were obtained utilizing Sigma-Plot 12.0, One-way
ANOVA was applied. Stars (*) indicate the significance level, *, P ≤ 0.05; **, P ≤ 0.01; ***, p
≤ 0.001; ns, P > 0.05 = no significance. (n= 3)
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Figure 10: Cell Viability obtained by Trypan Blue Exclusion Test utilizing hemocytometer
for (RAW 264.7, PAM-212, and Co-culture) at 48 Hours post-infection with HSV-1.
All monolayers and co-cultured cell lines (PAM-212, RAW 264.7/M0, and Co-culture) exhibited
a significant decrease in cell viability at 48 post infection (~16.6%, 8.1%, & 36.3%; P-value =
<0.001 P-value = <0.001, P-value = <0.001) respectively were compared to control. However; in
comparison between the different of cell lines, there was no significant difference between the
keratinocytes and macrophages M0 monolayers infected groups (~5.1 %, P-value = 0.282) while
the co-cultured cell lines infected group showed a grate significant decrease in cell viability at 48
hours (~19 %, 24.1%; P-value = <0.001, P-value = <0.001) compared to (PAM-212 & RAW
264.7/M0) respectively. The mean illustrates the percentages of viable cells and error bars
represent standard error ±. The statistics were obtained utilizing Sigma-Plot 12.0, One-way
ANOVA was applied. Stars (*) indicate the significance level, ***, p ≤ 0.001; ns = no
significance. (n= 3)
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Figure 11: Cell Viability obtained by Trypan Blue Exclusion Test utilizing
hemocytometer for (RAW 264.7, PAM-212, and Co-culture) at 72 Hours post-infection
with HSV-1.
All monolayers and co-cultured cell lines (PAM-212, RAW 264.7/M0, and Co-culture)
exhibited a grate significant decrease in cell viability at 72 post infection (~46.7%, 46.3%, &
64.6%; P-value = <0.001 P-value = <0.001, P-value = <0.001) respectively. However; in
comparison between the different of cell lines, there was no significant difference between
the keratinocytes and macrophages M0 monolayers infected groups (~6.1%, P-value = 0.323)
while the co-cultured cell lines infected group showed a grate significant decrease in cell
viability at 72 hours (~26.7 %, 20.6%; P-value = <0.001, P-value = 0.003) compared to
(PAM-212 & RAW 264.7) respectively. The mean illustrates the percentages of viable cells
and error bars represent standard error ±. The statistics were obtained utilizing Sigma-Plot
12.0, One-way ANOVA was applied. Stars (*) indicate the significance level, **, P ≤ 0.01;
***, p ≤ 0.001; ns, P > 0.05 = no significance. (n= 3)
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Figure 12: Morphological Changes exhibited by Keratinocytes (PAM-212), Macrophages
(RAW 264.7), Co-culture at Time-points of 24, 48, and 72 hours post-infection with HSV1. The solid arrow exhibits the changes in morphology. The head’s arrows show floating cells.
The dotted arrows show debris while the dotted circles illustrate the macrophages co-cultured
with keratinocytes.
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HSV-1 Titers Post Time-points

Figure 13: The Plaque Assay for Keratinocytes (PAM-212) Infected with HSV-1 at 24,
48, and 72 Hours. In keratinocytes (PAM-212) at 24 hours, plaques formation was observed
from 10-1 to 10-5. However, the virus titers were counted at x10-3, and the plaque formed per
ml (PFU/ml) was 12.6 X 10-3 in average. At 48 hours, plaques formation was observed from
10-1 to 10-10. The virus titers were counted at x10-8, and the plaque formed per ml (PFU/ml)
was 214 X 10-8 in average. While at 72 hours, plaques formation was observed from 10-1 to
10-10. The virus titers were counted at x10-8, and the plaque formed per ml (PFU/ml) was 224
X 10-8 in average. On the other hand, HSV-1 titers were significantly increased in the
keratinocytes from 24 to 48 and 72 hours respectively. In contrast, there was no significant
difference between virion replication at 48 and 72 hours. The mean illustrates virus titers and
error bars represent standard error ±. The statistics were obtained utilizing Sigma-Plot 12.0,
One-way ANOVA was applied. Stars (*) indicate the significance level, **, P ≤ 0.01; ***, p
≤ 0.001; ns, P > 0.05 = no significance. (n= 3)
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HSV-1 Titers Post Time-points

Figure 14: The Plaque Assay for Macrophages (RAW264.7) Infected with HSV-1 at 24, 48,
and 72 Hours. In macrophages (RAW 264.7/ M0) at 24 hours, plaques formation was observed
from 10-1 to 10-5. However, the virus titers were counted at x10-3, and the plaque formed per ml
(PFU/ml) was 65.6 X 10-3 in average. At 48 hours, plaques formation was only observed from 10-1
to 10-5 and there were no plaques formation beyond the dilution factor x10-5 as was demonstrated
by six trials. The virus titers were counted at x10-2, and the plaque formed per ml (PFU/ml) was
132 X 10-2 in average. While at 72 hours, plaques formation was observed from 10-1 to 10-10. The
virus titers were counted at x10-8, and the plaque formed per ml (PFU/ml) was 91 X 10-8 in
average. Moreover, HSV-1 titers were remarkably decreased in the macrophages (M0) from 24 to
48 hours. However, there was a large significant increase in virion titers at 72 hours compared to
24 and 48 hours. The mean illustrates virus titers and error bars represent standard error ±. The
statistics were obtained utilizing Sigma-Plot 12.0, One-way ANOVA was applied. Stars (*)
indicate the significance level, **, P ≤ 0.01; ***, p ≤ 0.001. (n= 3)
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Figure 15: The Plaque Assay for Co-culture (PAM-212 + M0) Infected with HSV-1 at
24, 48, and 72 Hours. In co-culture model (PAM-212 + RAW 264.7/M0) at 24 hours,
plaques formation was observed only at 10-1 in one plate while other plate did not show any
plaques formation beyond the dilution factor x10-1 as was demonstrated by four trials.
However, the virus titers were counted at x10-1, and the plaque formed per ml (PFU/ml) was
55.3 X 10-1 in average. At 48 hours, plaques formation was observed from 10-1 to 10-10. The
virus titers were counted at x10-8, and the plaque formed per ml (PFU/ml) was 34.6 X 10-8 in
average. While at 72 hours, plaques formation was observed from 10-1 to 10-10. The virus
titers were counted at x10-8, and the plaque formed per ml (PFU/ml) was 91.3 X 10-8 in
average. However, HSV-1 titers were noticeably decreased in the co-culture model at 24
compared to virus titers at 48 and 72 hours respectively. Nevertheless, there was a slightly
difference between virion concentrations at 48 and 72 hours. The mean illustrates virus titers
and error bars represent standard error ±. The statistics were obtained utilizing Sigma-Plot
12.0, One-way ANOVA was applied. Stars (*) indicate the significance level, *, P ≤ 0.05;
***, p ≤ 0.001. (n= 3)
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Figure 16: The Plaque Assay compared between all Cell Lines (RAW 264.7, PAM-212,
and Co-culture) Infected with HSV-1 after 24 Hours. The keratinocytes (PAM-212)
monolayer exhibited less significant in virus concentration compared with macrophages at
24 hours (~5.1fold, P-value = <0.001). While the macrophages (RAW 264.7 /M0)
monolayer showed the most significant increase in HSV-1 replication at 24 hours compared
to 24 and 72 hours (~5.1 fold, 118 fold, P-value = <0.001, P-value = <0.001) respectively.
On the other hand, the co-cultured cell lines (PAM-212 + RAW 264.7/M0) exhibited the
lowest significant in virion titers compared to the monolayers infected groups at 24 hours
(~22.7 fold, 118 fold, P-value = <0.001, P-value = <0.001) respectively. The mean
illustrates virus titers and error bars represent standard error ±. The statistics were obtained
utilizing Sigma-Plot 12.0, One-way ANOVA was applied. Stars (*) indicate the
significance level, ***, p ≤ 0.001. (n= 3)

49

Figure 17: The Plaque Assay compared between all Cell Lines (RAW 264.7, PAM-212,
and Co-culture) Infected with HSV-1 after 48 Hours. The keratinocytes (PAM-212)
monolayer exhibited no significant in virus concentration compared with co-culture at 48
hours (~1.5 fold, P-value = 0.078). While the macrophages (RAW 264.7 /M0) monolayer
showed the lowest significant in HSV-1 replication at 48 hours compared to 24 and 72 hours
(~1.65X106 fold, 1.11X106 fold, P-value = 0.008, P-value = 0.012) respectively. The mean
illustrates virus titers and error bars represent standard error ±. The statistics were obtained
utilizing Sigma-Plot 12.0, One-way ANOVA was applied. Stars (*) indicate the significance
level, * , P ≤ 0.05; **, p ≤ 0.01; ns, P > 0.05 = no significance. (n= 3)
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Figure 18: The Plaque Assay compared between all Cell Lines (RAW 264.7, PAM-212,
and Co-culture) Infected with HSV-1 after 72 Hours. The keratinocytes (PAM-212)
monolayer exhibited a significant increase in virus concentration compared with
macrophages (M0) and co-culture at 72 hours (~5.6 fold, 2.44 fold, P-value = <0.001, Pvalue = <0.001). While the macrophages (RAW 264.7 /M0) monolayer showed the less
significant in HSV-1 replication at 72 hours compared to keratinocytes and co-culture (~5.6
fold, 2.3 fold, P-value = <0.001, P-value = 0.052) respectively. The mean illustrates virus
titers and error bars represent standard error ±. The statistics were obtained utilizing SigmaPlot 12.0, One-way ANOVA was applied. Stars (*) indicate the significance level, **, p ≤
0.01, ***, p ≤ 0.001; ns, P > 0.05 = no significance. (n= 3)
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Figure 19: This Line Graph illustrates and Summarizes the Plaque Assay compared
between all Cell Lines (RAW 264.7, PAM-212, and Co-culture) Infected with HSV-1
after 24, 48, and 72 Hours. The dark dotted line represents the keratinocytes (PAM-212),
the gray dotted line represents the macrophages (M0), and the solid line represents the coculture. The mean illustrates virus titers and error bars represent standard error ±. The
statistics were obtained utilizing Sigma-Plot 12.0, One-way ANOVA was applied.
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Figure 20: Plaque Formation for Keratinocytes (PAM-212) after 24, 48, 72 hours
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Figure 21: Plaque Formation for Macrophages (RAW 264.7) after 24, 48, 72 hours
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Figure 22: Plaque Formation for Co-culture (PAM-212 & RAW 264.7) after 24, 48, 72 hours
55

REFERENCES
1. Bodet, C., Chandad, F., & Grenier, D. (2006). Original article: Inflammatory
responses of a macrophage/epithelial cell co-culture model to mono and mixed
infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella
forsythia. Microbes And Infection, 827-35. doi:10.1016/j.micinf.2005.05.015
2. Vikas S., Fauzul M., and Tulika P. Comparative Genomics of Herpesviridae
Family to Look for Potential Signatures of Human Infecting Strains. International
Journal of Genomics, vol. 2016, Article ID 9543274, 10 pages, 2016.
doi:10.1155/2016/9543274
3. Søby, S., Laursen, R. R., Østergaard, L., & Melchjorsen, J. (2012). HSV-1induced chemokine expression via IFI16-dependent and IFI16-independent
pathways in human monocyte-derived macrophages. Herpesviridae, 3(1), 6-12.
doi:10.1186/2042-4280-3-6
4. Cunningham, A. L., Diefenbach, R. J., Miranda-Saksena, M., Bosnjak, L., Kim,
M., Jones, C., & Douglas, M. W. (2006). The cycle of human herpes simplex
virus infection: virus transport and immune control. The Journal Of Infectious
Diseases, 194 Suppl 1S11-S18.
5. Usatine, R. P., & Tinitigan, R. (2010). Nongenital herpes simplex virus. American
Family Physician, 82(9), 1075-1082.
6. Manservigi R., Argnani R., & Marconi P. 2010. HSV Recombinant Vectors for
Gene Therapy. The Open Virology Journal. 4:123-156.
7. Eckert, R. L., & Rorke, E. A. (1989). Molecular biology of keratinocyte
differentiation. Environmental Health Perspectives, 80, 109–116.
56

8. Losquadro, W. D. (n.d). Anatomy of the Skin and the Pathogenesis of
Nonmelanoma Skin Cancer. Facial Plastic Surgery Clinics Of North
America, 25(3), 283-+.
9. Thier, K., Petermann, P., Rahn, E., Rothamel, D., Bloch, W., & Knebel-Mörsdorf,
D. d. (2017). Mechanical Barriers Restrict Invasion of Herpes Simplex Virus 1
into Human Oral Mucosa. Journal Of Virology, 91(22), 1-13.
10. Tron, V. A., Coughlin, M. D., Jang, D. E., Stanisz, J., & Sauder, D. N. (1990).
Expression and modulation of nerve growth factor in murine keratinocytes (PAM
212). The Journal of Clinical Investigation, 85(4), 1085-1089.
11. Sayers CL, Elliott G. 2016. Herpes simplex virus 1 enters human keratinocytes by
a nectin-1-dependent, rapid plasma membrane fusion pathway that functions at
low temperature. J Virol 90:10379 –10389.
12. Krummenacher C., Baribaud I., Sanzo J.F., Cohen G.H., & Eisenberg R.J. 2002.
Effects of Herpes Simplex Virus Structure and Function of Nectin-1/HveC.
Journal of Virology. 76(5):2424-2433.
13. Mosser, D. M., & Edwards, J. P. (2008). Exploring the full spectrum of
macrophage activation. Nature Reviews. Immunology, 8(12), 958-969.
doi:10.1038/nri2448
14. van Furth, R., Cohn, Z. A., Hirsch, J. G., Humphrey, J. H., Spector, W. G., &
Langevoort, H. L. (1972). The mononuclear phagocyte system: a new
classification of macrophages, monocytes, and their precursor cells. Bulletin Of
The World Health Organization, 46(6), 845-852.

57

15. Wang, N., Liang, H., & Zen, K. (2014). Molecular mechanisms that influence the
macrophage m1-m2 polarization balance. Frontiers in Immunology, 5614.
doi:10.3389/fimmu.2014.00614
16. Whitley, R. J., & Roizman, B. (2001). Herpes simplex virus
infections. Lancet, 357(9267), 1513.
17. Diefenbach, R. J., Miranda-Saksena, M., Douglas, M. W., & Cunningham, A. L.
(2008). Transport and egress of herpes simplex virus in neurons. Reviews In
Medical Virology, 18(1), 35-51.
18. Malkowska, M., Kokoszynska, K., Dymecka, M., Rychlewski, L., & Wyrwicz, L.
S. (2013). Alphaherpesvirinae and Gammaherpesvirinae glycoprotein L and CMV
UL130 originate from chemokines. Virology Journal, 101. doi:10.1186/1743422X-10-1
19. Rahn, E., Petermann, P., Hsu, M., Rixon, F. J., & Knebel-Mörsdorf, D. (2011).
Entry Pathways of Herpes Simplex Virus Type 1 into Human Keratinocytes Are
Dynamin- and Cholesterol- Dependent. Plos ONE, 6(10), 1-13.
doi:10.1371/journal.pone.0025464
20. Kather, A., Raftery, M. J., Lippmann, J., Schoenrich, G., Devi-Rao, G., SandriGoldin, R. M., & Giese, T. (n.d). Herpes Simplex Virus Type 1 (HSV-1)-Induced
Apoptosis in Human Dendritic Cells as a Result of Downregulation of Cellular
FLICE-Inhibitory Protein and Reduced Expression of HSV-1 Antiapoptotic
Latency-Associated Transcript Sequences. Journal Of Virology, 84(2), 10341046.

58

21. Xu, H., Su, C., Pearson, A., Mody, C. H., & Zheng, C. (2017). Herpes Simplex
Virus 1 UL24 Abrogates the DNA Sensing Signal Pathway by Inhibiting NF-κB
Activation. Journal Of Virology, 91(7), doi:10.1128/JVI.00025-17
22. Connolly, S. A., Jackson, J. O., Jardetzky, T. S., & Longnecker, R. r. (2011).
Fusing structure and function: a structural view of the herpesvirus entry
machinery. Nature Reviews Microbiology, 9(5), 369-381.
23. Barron, M., Pfeffer, K., Scheu, S., Krummenacher, C., Petermann, P., Thier, K.,
& ... Pfeffer, K. (n.d). Entry Mechanisms of Herpes Simplex Virus 1 into Murine
Epidermis: Involvement of Nectin-1 and Herpesvirus Entry Mediator as Cellular
Receptors. Journal Of Virology, 89(1), 262-274.
24. Heldwein, E. E., & Krummenacher, C. (2008). Entry of herpesviruses into
mammalian cells. Cellular And Molecular Life Sciences: CMLS, 65(11), 16531668. doi:10.1007/s00018-008-7570-z
25. Suazo, P. A., Ibañez, F. J., Retamal-Díaz, A. R., Paz-Fiblas, M. V., Bueno, S. M.,
Kalergis, A. M., & González, P. A. (2015). Evasion of early antiviral responses
by herpes simplex viruses. Mediators Of Inflammation, 2015593757.
doi:10.1155/2015/593757
26. Mettenleiter, T. C., Klupp, B. G., & Granzow, H. (2005). Entry of Pseudorabies
Virus: an Immunogold-Labeling Study.
27. Paladino, P., & Mossman, K. L. (2009). Mechanisms employed by herpes simplex
virus 1 to inhibit the interferon response. Journal Of Interferon & Cytokine
Research: The Official Journal Of The International Society For Interferon And
Cytokine Research, 29(9), 599-607. doi:10.1089/jir.2009.0074
59

28. Ward, P. L., Ogle, W. O., & Roizman, B. (1996). Assemblons: nuclear structures
defined by aggregation of immature capsids and some tegument proteins of
herpes simplex virus 1. Journal Of Virology, 70(7), 4623-4631.
29. Torseth, J. W., Nickoloff, B. J., Basham, T. Y., & Merigan, T. C. (1987). Beta
interferon produced by keratinocytes in human cutaneous infection with herpes
simplex virus. The Journal Of Infectious Diseases, 155(4), 641-648.
30. Mossman, K. L., Macgregor, P. F., Rozmus, J. J., Goryachev, A. B., Edwards, A.
M., & Smiley, J. R. (2001). Herpes simplex virus triggers and then disarms a host
antiviral response. Journal Of Virology, 75(2), 750-758.
31. Eidson, K. M., Hobbs, W. E., Manning, B. J., Carlson, P., & DeLuca, N. A.
(2002). Expression of herpes simplex virus ICP0 inhibits the induction of
interferon-stimulated genes by viral infection. Journal Of Virology, 76(5), 21802191.
32. Megan H., O., Neal A., D., & David M., K. (2012). Nuclear IFI16 induction of
IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral
ICP0 protein. Proceedings Of The National Academy Of Sciences Of The United
States Of America, (44), 17748.
33. Zhang, J., Liu, H., & Wei, B. (n.d). Immune response of T cells during herpes
simplex virus type 1 (HSV-1) infection. Journal Of Zhejiang University-Science
B, 18(4), 277-288.
34. Johnson, K. E., Chikoti, L., & Chandran, B. (n.d). Herpes Simplex Virus 1
Infection Induces Activation and Subsequent Inhibition of the IFI16 and NLRP3
Inflammasomes. Journal Of Virology, 87(9), 5005-5018.
60

35. Ellermann-Eriksen, S. (2005). Macrophages and cytokines in the early defence
against herpes simplex virus. Virology Journal, 259.
36. Lee, D. H., & Ghiasi, H. (n.d). Roles of M1 and M2 Macrophages in Herpes
Simplex Virus 1 Infectivity. Journal Of Virology, 91(15),
37. Suazo, P. A., Ibañez, F. J., Retamal-Díaz, A. R., Paz-Fiblas, M. V., Bueno, S. M.,
Kalergis, A. M., & González, P. A. (2015). Evasion of early antiviral responses
by herpes simplex viruses. Mediators Of Inflammation, 2015593757.
doi:10.1155/2015/593757
38. Miettinen, J. J., Matikainen, S., & Nyman, T. A. (2012). Global secretome
characterization of herpes simplex virus 1-infected human primary
macrophages. Journal Of Virology, 86(23), 12770-12778. doi:10.1128/JVI.0154512
39. Milora, K. A., Uppalapati, S. R., Sanmiguel, J. C., Zou, W., & Jensen, L. E.
(2017). Interleukin-36β provides protection against HSV-1 infection, but does not
modulate initiation of adaptive immune responses. Scientific Reports, 7(1), 5799.
doi:10.1038/s41598-017-05363-4
40. Amir S., Y., Greta, G., Nicolas, R., Stefan K., D., Aubry, T., Isabelle, C., & ...
Marc, F. (2010). Nanoparticles activate the NLR pyrin domain containing 3
(Nlrp3) inflammasome and cause pulmonary inflammation through release of IL1α and IL-1β. Proceedings Of The National Academy Of Sciences Of The United
States Of America, (45), 19449.

61

41. Syrjänen, S., Mikola, H., Nykänen, M., & Hukkanen, V. (1996). In vitro
establishment of lytic and nonproductive infection by herpes simplex virus type 1
in three-dimensional keratinocyte culture. Journal Of Virology, 70(9), 6524-6528.
42. Horbul, J. E., Schmechel, S. C., Miller, B. L., Rice, S. A., & Southern, P. J.
(2011). Herpes Simplex Virus-Induced Epithelial Damage and Susceptibility to
Human Immunodeficiency Virus Type 1 Infection in Human Cervical Organ
Culture. Plos ONE, 6(7), 1-13. doi:10.1371/journal.pone.0022638

62

